Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1994 Oct;145(4):802–817.

The cell type-specific IGF2 expression during early human development correlates to the pattern of overgrowth and neoplasia in the Beckwith-Wiedemann syndrome.

F Hedborg 1, L Holmgren 1, B Sandstedt 1, R Ohlsson 1
PMCID: PMC1887333  PMID: 7943172

Abstract

Overstimulation by insulin-like growth factor II is implied in several overgrowth conditions and childhood cancers. We have therefore studied spatial and temporal expression patterns of the insulin-like growth factor II gene (IGF2) and the insulin-like growth factor type 1 receptor gene during normal human development (5.5 to 23.0 weeks postfertilization). The set of cell types with the most abundant IGF2 expression correlated strikingly to the organomegaly and tumor predisposition of the Beckwith-Wiedemann syndrome. Intrauterine growth and postnatal organ weights of a prematurely born child with a full-blown syndrome are presented. The cell type-specific IGF2 expression of these organs and of multifocal Wilms' tumors from two other children affected by the Beckwith-Wiedemann syndrome were also studied. The results clarify and extend previous findings concerning human prenatal IGF2 expression and are consistent with a short range overstimulatory role of locally produced IGF II ensuing after the first trimester in the Beckwith-Wiedemann syndrome.

Full text

PDF
802

Images in this article

805Figure 1
on p.805
807Figure 3
on p.807
809Figure 4
on p.809
811Figure 6
on p.811

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ayer-le Lievre C., Ståhlbom P. A., Sara V. R. Expression of IGF-I and -II mRNA in the brain and craniofacial region of the rat fetus. Development. 1991 Jan;111(1):105–115. doi: 10.1242/dev.111.1.105. [DOI] [PubMed] [Google Scholar]
  2. Baker J., Liu J. P., Robertson E. J., Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell. 1993 Oct 8;75(1):73–82. [PubMed] [Google Scholar]
  3. Bondy C. A., Werner H., Roberts C. T., Jr, LeRoith D. Cellular pattern of insulin-like growth factor-I (IGF-I) and type I IGF receptor gene expression in early organogenesis: comparison with IGF-II gene expression. Mol Endocrinol. 1990 Sep;4(9):1386–1398. doi: 10.1210/mend-4-9-1386. [DOI] [PubMed] [Google Scholar]
  4. Brice A. L., Cheetham J. E., Bolton V. N., Hill N. C., Schofield P. N. Temporal changes in the expression of the insulin-like growth factor II gene associated with tissue maturation in the human fetus. Development. 1989 Jul;106(3):543–554. doi: 10.1242/dev.106.3.543. [DOI] [PubMed] [Google Scholar]
  5. DeChiara T. M., Efstratiadis A., Robertson E. J. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature. 1990 May 3;345(6270):78–80. doi: 10.1038/345078a0. [DOI] [PubMed] [Google Scholar]
  6. DeChiara T. M., Robertson E. J., Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell. 1991 Feb 22;64(4):849–859. doi: 10.1016/0092-8674(91)90513-x. [DOI] [PubMed] [Google Scholar]
  7. Drummond I. A., Madden S. L., Rohwer-Nutter P., Bell G. I., Sukhatme V. P., Rauscher F. J., 3rd Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science. 1992 Jul 31;257(5070):674–678. doi: 10.1126/science.1323141. [DOI] [PubMed] [Google Scholar]
  8. Drut R., Jones M. C. Congenital pancreatoblastoma in Beckwith-Wiedemann syndrome: an emerging association. Pediatr Pathol. 1988;8(3):331–339. doi: 10.3109/15513818809042976. [DOI] [PubMed] [Google Scholar]
  9. El-Badry O. M., Helman L. J., Chatten J., Steinberg S. M., Evans A. E., Israel M. A. Insulin-like growth factor II-mediated proliferation of human neuroblastoma. J Clin Invest. 1991 Feb;87(2):648–657. doi: 10.1172/JCI115042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Emery L. G., Shields M., Shah N. R., Garbes A. Neuroblastoma associated with Beckwith-Wiedemann syndrome. Cancer. 1983 Jul 1;52(1):176–179. doi: 10.1002/1097-0142(19830701)52:1<176::aid-cncr2820520132>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  11. Engström W., Lindham S., Schofield P. Wiedemann-Beckwith syndrome. Eur J Pediatr. 1988 Jun;147(5):450–457. doi: 10.1007/BF00441965. [DOI] [PubMed] [Google Scholar]
  12. Falik-Borenstein T. C., Korenberg J. R., Davos I., Platt L. D., Gans S., Goodman B., Schreck R., Graham J. M., Jr Congenital gastric teratoma in Wiedemann-Beckwith syndrome. Am J Med Genet. 1991 Jan;38(1):52–57. doi: 10.1002/ajmg.1320380113. [DOI] [PubMed] [Google Scholar]
  13. Giannoukakis N., Deal C., Paquette J., Goodyer C. G., Polychronakos C. Parental genomic imprinting of the human IGF2 gene. Nat Genet. 1993 May;4(1):98–101. doi: 10.1038/ng0593-98. [DOI] [PubMed] [Google Scholar]
  14. Goustin A. S., Betsholtz C., Pfeifer-Ohlsson S., Persson H., Rydnert J., Bywater M., Holmgren G., Heldin C. H., Westermark B., Ohlsson R. Coexpression of the sis and myc proto-oncogenes in developing human placenta suggests autocrine control of trophoblast growth. Cell. 1985 May;41(1):301–312. doi: 10.1016/0092-8674(85)90083-2. [DOI] [PubMed] [Google Scholar]
  15. Gray A., Tam A. W., Dull T. J., Hayflick J., Pintar J., Cavenee W. K., Koufos A., Ullrich A. Tissue-specific and developmentally regulated transcription of the insulin-like growth factor 2 gene. DNA. 1987 Aug;6(4):283–295. doi: 10.1089/dna.1987.6.283. [DOI] [PubMed] [Google Scholar]
  16. Greenwood R. D., Somer A., Rosenthal A., Craenen J., Nadas A. S. Cardiovascular abnormalities in the Beckwith-Wiedemann syndrome. Am J Dis Child. 1977 Mar;131(3):293–294. doi: 10.1001/archpedi.1977.02120160047007. [DOI] [PubMed] [Google Scholar]
  17. Haig D., Graham C. Genomic imprinting and the strange case of the insulin-like growth factor II receptor. Cell. 1991 Mar 22;64(6):1045–1046. doi: 10.1016/0092-8674(91)90256-x. [DOI] [PubMed] [Google Scholar]
  18. Han V. K., D'Ercole A. J., Lund P. K. Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science. 1987 Apr 10;236(4798):193–197. doi: 10.1126/science.3563497. [DOI] [PubMed] [Google Scholar]
  19. Han V. K., Lund P. K., Lee D. C., D'Ercole A. J. Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: identification, characterization, and tissue distribution. J Clin Endocrinol Metab. 1988 Feb;66(2):422–429. doi: 10.1210/jcem-66-2-422. [DOI] [PubMed] [Google Scholar]
  20. Henry I., Bonaiti-Pellié C., Chehensse V., Beldjord C., Schwartz C., Utermann G., Junien C. Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature. 1991 Jun 20;351(6328):665–667. doi: 10.1038/351665a0. [DOI] [PubMed] [Google Scholar]
  21. Hervonen A., Korkala O. The effect of hypoxia on the catecholamine content of human fetal abdominal paraganglia and adrenal medulla. Acta Obstet Gynecol Scand. 1972;51(1):17–24. doi: 10.3109/00016347209154963. [DOI] [PubMed] [Google Scholar]
  22. Humbel R. E. Insulin-like growth factors I and II. Eur J Biochem. 1990 Jul 5;190(3):445–462. doi: 10.1111/j.1432-1033.1990.tb15595.x. [DOI] [PubMed] [Google Scholar]
  23. Irving I. M. Exomphalos with macroglossia: a study of eleven cases. J Pediatr Surg. 1967 Dec;2(6):499–507. doi: 10.1016/s0022-3468(67)80003-4. [DOI] [PubMed] [Google Scholar]
  24. Junien C. Beckwith-Wiedemann syndrome, tumourigenesis and imprinting. Curr Opin Genet Dev. 1992 Jun;2(3):431–438. doi: 10.1016/s0959-437x(05)80154-6. [DOI] [PubMed] [Google Scholar]
  25. Koufos A., Grundy P., Morgan K., Aleck K. A., Hadro T., Lampkin B. C., Kalbakji A., Cavenee W. K. Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. Am J Hum Genet. 1989 May;44(5):711–719. [PMC free article] [PubMed] [Google Scholar]
  26. Lee J. E., Pintar J., Efstratiadis A. Pattern of the insulin-like growth factor II gene expression during early mouse embryogenesis. Development. 1990 Sep;110(1):151–159. doi: 10.1242/dev.110.1.151. [DOI] [PubMed] [Google Scholar]
  27. Nordenskjöld A., Hedborg F., Luthman H., Nordenskjöld M. Tight linkage between the Beckwith-Wiedemann syndrome and a microsatellite marker for the TH locus. Hum Genet. 1993 Oct 1;92(3):296–298. doi: 10.1007/BF00244475. [DOI] [PubMed] [Google Scholar]
  28. Ogawa O., Becroft D. M., Morison I. M., Eccles M. R., Skeen J. E., Mauger D. C., Reeve A. E. Constitutional relaxation of insulin-like growth factor II gene imprinting associated with Wilms' tumour and gigantism. Nat Genet. 1993 Dec;5(4):408–412. doi: 10.1038/ng1293-408. [DOI] [PubMed] [Google Scholar]
  29. Ogawa O., Eccles M. R., Szeto J., McNoe L. A., Yun K., Maw M. A., Smith P. J., Reeve A. E. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature. 1993 Apr 22;362(6422):749–751. doi: 10.1038/362749a0. [DOI] [PubMed] [Google Scholar]
  30. Ohlsson R., Hedborg F., Holmgren L., Walsh C., Ekström T. J. Overlapping patterns of IGF2 and H19 expression during human development: biallelic IGF2 expression correlates with a lack of H19 expression. Development. 1994 Feb;120(2):361–368. doi: 10.1242/dev.120.2.361. [DOI] [PubMed] [Google Scholar]
  31. Ohlsson R., Holmgren L., Glaser A., Szpecht A., Pfeifer-Ohlsson S. Insulin-like growth factor 2 and short-range stimulatory loops in control of human placental growth. EMBO J. 1989 Jul;8(7):1993–1999. doi: 10.1002/j.1460-2075.1989.tb03606.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Ohlsson R., Larsson E., Nilsson O., Wahlström T., Sundström P. Blastocyst implantation precedes induction of insulin-like growth factor II gene expression in human trophoblasts. Development. 1989 Jul;106(3):555–559. doi: 10.1242/dev.106.3.555. [DOI] [PubMed] [Google Scholar]
  33. Ohlsson R., Nyström A., Pfeifer-Ohlsson S., Töhönen V., Hedborg F., Schofield P., Flam F., Ekström T. J. IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome. Nat Genet. 1993 May;4(1):94–97. doi: 10.1038/ng0593-94. [DOI] [PubMed] [Google Scholar]
  34. Orozco-Florian R., McBride J. A., Favara B. E., Steele A., Brown S. J., Steele P. Congenital hepatoblastoma and Beckwith-Wiedemann syndrome: a case study including DNA ploidy profiles of tumor and adrenal cytomegaly. Pediatr Pathol. 1991 Jan-Feb;11(1):131–142. doi: 10.3109/15513819109064749. [DOI] [PubMed] [Google Scholar]
  35. Paik S., Rosen N., Jung W., You J. M., Lippman M. E., Perdue J. F., Yee D. Expression of insulin-like growth factor-II mRNA in fetal kidney and Wilms' tumor. An in situ hybridization study. Lab Invest. 1989 Nov;61(5):522–526. [PubMed] [Google Scholar]
  36. Persson P. H., Weldner B. M. Intra-uterine weight curves obtained by ultrasound. Acta Obstet Gynecol Scand. 1986;65(2):169–173. doi: 10.3109/00016348609158374. [DOI] [PubMed] [Google Scholar]
  37. Ping A. J., Reeve A. E., Law D. J., Young M. R., Boehnke M., Feinberg A. P. Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. Am J Hum Genet. 1989 May;44(5):720–723. [PMC free article] [PubMed] [Google Scholar]
  38. Pritchard-Jones K., Fleming S., Davidson D., Bickmore W., Porteous D., Gosden C., Bard J., Buckler A., Pelletier J., Housman D. The candidate Wilms' tumour gene is involved in genitourinary development. Nature. 1990 Jul 12;346(6280):194–197. doi: 10.1038/346194a0. [DOI] [PubMed] [Google Scholar]
  39. Rainier S., Johnson L. A., Dobry C. J., Ping A. J., Grundy P. E., Feinberg A. P. Relaxation of imprinted genes in human cancer. Nature. 1993 Apr 22;362(6422):747–749. doi: 10.1038/362747a0. [DOI] [PubMed] [Google Scholar]
  40. Rechler M. M., Nissley S. P. The nature and regulation of the receptors for insulin-like growth factors. Annu Rev Physiol. 1985;47:425–442. doi: 10.1146/annurev.ph.47.030185.002233. [DOI] [PubMed] [Google Scholar]
  41. Reddy J. K., Schimke R. N., Chang C. H., Svoboda D. J., Slaven J., Therou L. Beckwith-Wiedemann syndrome. Wilms' tumor, cardiac hamartoma, persistent visceromegaly, and glomeruloneogenesis in a 2-year-old boy. Arch Pathol. 1972 Dec;94(6):523–532. [PubMed] [Google Scholar]
  42. Reeve A. E., Eccles M. R., Wilkins R. J., Bell G. I., Millow L. J. Expression of insulin-like growth factor-II transcripts in Wilms' tumour. Nature. 1985 Sep 19;317(6034):258–260. doi: 10.1038/317258a0. [DOI] [PubMed] [Google Scholar]
  43. Roe T. F., Kershnar A. K., Weitzman J. J., Madrigal L. S. Beckwith's syndrome with extreme organ hyperplasia. Pediatrics. 1973 Sep;52(3):372–381. [PubMed] [Google Scholar]
  44. Roemer V. M., Kieback D. G., Bühler K. Gestationszeit und Geburtsgewicht. 2. Mitteilung: Die Plazenta und mütterliche Kofaktoren. Z Geburtshilfe Perinatol. 1991 Sep-Oct;195(5):195–208. [PubMed] [Google Scholar]
  45. SCHULZ D. M., GIORDANO D. A., SCHULZ D. H. Weights of organs of fetuses and infants. Arch Pathol. 1962 Sep;74:244–250. [PubMed] [Google Scholar]
  46. Sara V. R., Hall K. Insulin-like growth factors and their binding proteins. Physiol Rev. 1990 Jul;70(3):591–614. doi: 10.1152/physrev.1990.70.3.591. [DOI] [PubMed] [Google Scholar]
  47. Schneid H., Vazquez M. P., Seurin D., le Bouc Y. Loss of heterozygosity in non-tumoral tissue in two children with Beckwith-Wiedemann syndrome. Growth Regul. 1991 Dec;1(4):168–170. [PubMed] [Google Scholar]
  48. Scott J., Cowell J., Robertson M. E., Priestley L. M., Wadey R., Hopkins B., Pritchard J., Bell G. I., Rall L. B., Graham C. F. Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues. Nature. 1985 Sep 19;317(6034):260–262. doi: 10.1038/317260a0. [DOI] [PubMed] [Google Scholar]
  49. Shapiro L. R., Duncan P. A., Davidian M. M., Singer N. The placenta in familial beckwith-wiedemann syndrome. Birth Defects Orig Artic Ser. 1982;18(3B):203–206. [PubMed] [Google Scholar]
  50. Sirinelli D., Silberman B., Baudon J. J., Sinnassamy P., Gruner M., Montagne J. P. Beckwith-wiedemann syndrome and neural crest tumors. A report of two cases. Pediatr Radiol. 1989;19(4):242–245. doi: 10.1007/BF02386843. [DOI] [PubMed] [Google Scholar]
  51. Sotelo-Avila C., Gonzalez-Crussi F., Fowler J. W. Complete and incomplete forms of Beckwith-Wiedemann syndrome: their oncogenic potential. J Pediatr. 1980 Jan;96(1):47–50. doi: 10.1016/s0022-3476(80)80322-2. [DOI] [PubMed] [Google Scholar]
  52. Stylianopoulou F., Efstratiadis A., Herbert J., Pintar J. Pattern of the insulin-like growth factor II gene expression during rat embryogenesis. Development. 1988 Jul;103(3):497–506. doi: 10.1242/dev.103.3.497. [DOI] [PubMed] [Google Scholar]
  53. Taxi J. The chromaffin and chromaffin-like cells in the autonomic nervous system. Int Rev Cytol. 1979;57:283–343. doi: 10.1016/s0074-7696(08)61465-5. [DOI] [PubMed] [Google Scholar]
  54. Viljoen D., Ramesar R. Evidence for paternal imprinting in familial Beckwith-Wiedemann syndrome. J Med Genet. 1992 Apr;29(4):221–225. doi: 10.1136/jmg.29.4.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Voutilainen R., Miller W. L. Developmental and hormonal regulation of mRNAs for insulin-like growth factor II and steroidogenic enzymes in human fetal adrenals and gonads. DNA. 1988 Jan-Feb;7(1):9–15. doi: 10.1089/dna.1988.7.9. [DOI] [PubMed] [Google Scholar]
  56. Weksberg R., Shen D. R., Fei Y. L., Song Q. L., Squire J. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nat Genet. 1993 Oct;5(2):143–150. doi: 10.1038/ng1093-143. [DOI] [PubMed] [Google Scholar]
  57. Wöckel W., Scheibner K., Lageman A. A variant of the Wiedemann-Beckwith syndrome. Eur J Pediatr. 1981 Feb;135(3):319–324. doi: 10.1007/BF00442111. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES